Literature DB >> 22255342

Development and evaluation of a social robot platform for therapy in autism.

Daniele Mazzei1, Nicole Lazzeri, Lucia Billeci, Roberta Igliozzi, Alice Mancini, Arti Ahluwalia, Filippo Muratori, Danilo De Rossi.   

Abstract

People with ASD (Autism Spectrum Disorders) have difficulty in managing interpersonal relationships and common life social situations. A modular platform for Human Robot Interaction and Human Machine Interaction studies has been developed to manage and analyze therapeutic sessions in which subjects are driven by a psychologist through simulated social scenarios. This innovative therapeutic approach uses a humanoid robot called FACE capable of expressing and conveying emotions and empathy. Using FACE as a social interlocutor the psychologist can emulate real life scenarios where the emotional state of the interlocutor is adaptively adjusted through a semi closed loop control algorithm which uses the ASD subject's inferred "affective" state as input. Preliminary results demonstrate that the platform is well accepted by ASDs and can be consequently used as novel therapy for social skills training.

Entities:  

Mesh:

Year:  2011        PMID: 22255342     DOI: 10.1109/IEMBS.2011.6091119

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  3 in total

1.  Impact of robot-mediated interaction system on joint attention skills for children with autism.

Authors:  Zhi Zheng; Lian Zhang; Esubalew Bekele; Amy Swanson; Julie A Crittendon; Zachary Warren; Nilanjan Sarkar
Journal:  IEEE Int Conf Rehabil Robot       Date:  2013-06

2.  Emotional Expression in Simple Line Drawings of a Robot's Face Leads to Higher Offers in the Ultimatum Game.

Authors:  Kazunori Terada; Chikara Takeuchi
Journal:  Front Psychol       Date:  2017-05-22

3.  Inference of human affective states from psychophysiological measurements extracted under ecologically valid conditions.

Authors:  Alberto Betella; Riccardo Zucca; Ryszard Cetnarski; Alberto Greco; Antonio Lanatà; Daniele Mazzei; Alessandro Tognetti; Xerxes D Arsiwalla; Pedro Omedas; Danilo De Rossi; Paul F M J Verschure
Journal:  Front Neurosci       Date:  2014-09-24       Impact factor: 4.677

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.